Is it rational to continue anti-neoplastics with minimal toxicity even after progression in patients with no other options? Possibly yes
| Image |  |
|---|---|
| Description | scientific article published in January 2014 |
| Author/s |
author: Ahmet Taner Sumbul |
| Publication date | January 1, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |